Raymond James & Associates’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.06M Sell
58,171
-136,601
-70% -$2.42M ﹤0.01% 2655
2024
Q2
$3.21M Sell
194,772
-342,347
-64% -$5.24M ﹤0.01% 1876
2024
Q1
$7.6M Sell
537,119
-315,422
-37% -$4.76M 0.01% 1312
2023
Q4
$14.7M Sell
852,541
-92,948
-10% -$1.42M 0.01% 877
2023
Q3
$14.4M Buy
945,489
+30,349
+3% +$539K 0.01% 832
2023
Q2
$17.3M Sell
915,140
-12,275
-1% -$237K 0.01% 775
2023
Q1
$17.9M Sell
927,415
-13,458
-1% -$271K 0.02% 732
2022
Q4
$18.1M Buy
940,873
+93,320
+11% +$1.83M 0.02% 714
2022
Q3
$17.7M Buy
847,553
+786,965
+1,299% +$20M 0.02% 661
2022
Q2
$1.69M Sell
60,588
-176
-0.3% -$5.23K ﹤0.01% 2091
2022
Q1
$1.9M Buy
60,764
+5,307
+10% +$167K ﹤0.01% 2163
2021
Q4
$1.85M Sell
55,457
-6,090
-10% -$203K ﹤0.01% 2233
2021
Q3
$1.82M Sell
61,547
-507
-0.8% -$14.8K ﹤0.01% 2170
2021
Q2
$1.66M Buy
62,054
+7,793
+14% +$220K ﹤0.01% 2234
2021
Q1
$1.5M Sell
54,261
-16,069
-23% -$449K ﹤0.01% 2227
2020
Q4
$1.94M Sell
70,330
-23,103
-25% -$610K ﹤0.01% 1908
2020
Q3
$2.43M Buy
93,433
+55,264
+145% +$1.45M ﹤0.01% 1630
2020
Q2
$1.01M Buy
38,169
+3,588
+10% +$91.9K ﹤0.01% 2157
2020
Q1
$840K Sell
34,581
-10,603
-23% -$320K ﹤0.01% 2099
2019
Q4
$1.37M Buy
45,184
+4,292
+10% +$128K ﹤0.01% 2074
2019
Q3
$1.2M Buy
40,892
+2,224
+6% +$62.2K ﹤0.01% 2085
2019
Q2
$1.06M Sell
38,668
-5,088
-12% -$143K ﹤0.01% 2175
2019
Q1
$1.25M Sell
43,756
-241,588
-85% -$6.72M ﹤0.01% 2064
2018
Q4
$7.22M Sell
285,344
-25,479
-8% -$675K 0.01% 917
2018
Q3
$8.29M Buy
310,823
+1,612
+0.5% +$44.4K 0.01% 940
2018
Q2
$8.34M Sell
309,211
-637,637
-67% -$16.2M 0.01% 914
2018
Q1
$25M Buy
946,848
+113,302
+14% +$3.02M 0.04% 394
2017
Q4
$25M Buy
833,546
+93,975
+13% +$2.84M 0.05% 388
2017
Q3
$22M Buy
739,571
+462,887
+167% +$14.1M 0.04% 413
2017
Q2
$8.61M Buy
276,684
+258,612
+1,431% +$8.15M 0.02% 777
2017
Q1
$569K Buy
18,072
+2,265
+14% +$68.7K ﹤0.01% 2301
2016
Q4
$460K Buy
15,807
+1,209
+8% +$35.6K ﹤0.01% 2388
2016
Q3
$476K Sell
14,598
-761
-5% -$25.2K ﹤0.01% 2320
2016
Q2
$497K Sell
15,359
-8,103
-35% -$244K ﹤0.01% 2111
2016
Q1
$690K Sell
23,462
-18,389
-44% -$510K ﹤0.01% 1872
2015
Q4
$1.13M Buy
41,851
+6,715
+19% +$173K ﹤0.01% 1575
2015
Q3
$861K Sell
35,136
-3,430
-9% -$84.6K ﹤0.01% 1669
2015
Q2
$924K Sell
38,566
-817
-2% -$20.9K ﹤0.01% 1780
2015
Q1
$1.1M Sell
39,383
-14,148
-26% -$398K ﹤0.01% 1611
2014
Q4
$1.44M Buy
53,531
+23,950
+81% +$606K 0.01% 1338
2014
Q3
$686K Buy
29,581
+18,558
+168% +$450K ﹤0.01% 1716
2014
Q2
$265K Buy
+11,023
New +$263K ﹤0.01% 2085

Other funds holding HR

Raymond James & Associates's HR Position: Q3 2024 in Review

Raymond James & Associates reduced its Healthcare Realty (HR) stake by 70% in Q3 2024, selling an estimated $2.42M and leaving 58,171 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2655.

Raymond James & Associates first reported a position in HR in Q2 2014 and has held it in 42 quarters since. The position peaked at $25M in Q1 2018. 410 funds tracked by Wall St. Rank hold HR as of Q3 2024.

  • Raymond James & Associates held 58,171 shares of Healthcare Realty worth $1.06M as of Q3 2024.
  • Raymond James & Associates sold 136,601 Healthcare Realty shares in Q3 2024, an estimated $2.42M.
  • Healthcare Realty made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2655 holding.
  • Raymond James & Associates first reported a position in Healthcare Realty in Q2 2014 and has held it in 42 quarters since.
  • Raymond James & Associates's Healthcare Realty position peaked at $25M in Q1 2018.
  • 410 funds tracked by Wall St. Rank held Healthcare Realty as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.